ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
US Tech 100
16,585.60
-2.07%
Dow Jones
37,986.40
0.56%
Brent Oil
86.625
0.24%
Bitcoin
64,178.50
1.05%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Processa Pharmaceuticals Inc (PCSA) Quote

Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc (PCSA)

NASDAQ
1.58
0.02
(1.28%)
At close: April 19 4:00PM
Delayed by 15 minutes
1.45
-0.11
( -7.05% )
After Hours: 4:58PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.45
Bid
1.35
Ask
1.60
Volume
19,769
1.50 Day's Range 1.615
1.40 52 Week Range 18.00
Market Cap
1.946M
Previous Close
1.56
Open
1.53
Last Trade
130
@
1.45
(formt)
Last Trade Time
16:58:42
Financial Volume
$ 31,150
VWAP
1.5757
Average Volume (3m)
460,165
Shares Outstanding
1,231,574
Dividend Yield
-
PE Ratio
-0.17
Earnings Per Share (EPS)
-9.03
Revenue
-
Net Profit
-11.12M

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an or... Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100. Show more

Sector
-
Industry
-
Headquarters
Wilmington, Delaware, USA
Founded
1970
Processa Pharmaceuticals Inc is listed in the sector of the NASDAQ with ticker PCSA. The last closing price for Processa Pharmaceuticals was $1.56. Over the last year, Processa Pharmaceuticals shares have traded in a share price range of $ 1.40 to $ 18.00.

Processa Pharmaceuticals currently has 1,231,574 shares outstanding. The market capitalization of Processa Pharmaceuticals is $1.95 million. Processa Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.17.

PCSA Latest News

More News

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial

NGC-Cap demonstrated greater 5-FU exposure than monotherapy capecitabine at a significantly lower dose with a favorable clinical safety profile NGC-Cap holds potential for improved efficacy in...

April 11 2024
GlobeNewswire Inc.

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the...

March 28 2024
GlobeNewswire Inc.

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the...

March 25 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 21 2024
Edgar (US Regulatory)

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...

February 21 2024
GlobeNewswire Inc.

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...

February 14 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 06 2024
Edgar (US Regulatory)

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...

February 06 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.22-13.17365269461.671.781.4875421.5755459CS
4-0.74-33.78995433792.193.3051.44564162.36682871CS
12-2.9-66.66666666674.354.391.44601652.88333338CS
26-8.774-85.817683881110.22417.41.416407765.71850785CS
52-9.35-86.574074074110.8181.412974157.53688746CS
156-170.95-99.1589327146172.4184.81.448138813.07282371CS
260-74.55-98.092105263276284.7981.441804216.82824217CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSLRComplete Solaria Inc
$ 0.7615
(69.22%)
5.25M
OLBOLB Group Inc
$ 0.482
(46.06%)
1.06M
MNDRMobile health Network Solutions
$ 34.70
(27.25%)
401.64k
OMHOhmyhome Ltd
$ 0.5619
(14.67%)
22.04k
QMCOQuantum Corporation
$ 0.4498
(12.45%)
2.11k
VAXXVaxxinity Inc
$ 0.32
(-32.79%)
107.02k
RANIRani Therapeutics Holdings Inc
$ 6.39
(-9.62%)
3.18k
TIRXTian Ruixiang Holdings Ltd
$ 0.68
(-9.33%)
18.46k
SBFMSunshine Biopharma Inc
$ 1.61
(-8.78%)
469.37k
AGRIAgriFORCE Growing Systems Ltd
$ 0.1496
(-8.67%)
1.39M
CSLRComplete Solaria Inc
$ 0.7615
(69.22%)
5.25M
GDHGGolden Heaven Group Holdings Ltd
$ 0.2492
(6.04%)
2.09M
INTCIntel Corporation
$ 34.20
(0.00%)
1.91M
AAPLApple Inc
$ 164.97
(-0.02%)
1.63M
QQQInvesco QQQ Trust Series 1
$ 414.57
(-0.02%)
1.62M

PCSA Discussion

View Posts
Awl416 Awl416 1 week ago
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
👍️0
Monksdream Monksdream 3 weeks ago
PCSA under $3
👍️0
valleybenedetto valleybenedetto 2 months ago
https://www.secform4.com/insider-trading/1533743.htm
More insider buying
👍️0
valleybenedetto valleybenedetto 2 months ago
I love retarded posts like this.
👍️0
Sweetleaf Sweetleaf 3 months ago
LOL.. this is total garbage. Going under a dollar and then will reverse split again to eliminate current stock holders and start all over.
👍️0
Muhbruh Muhbruh 3 months ago
bullish
$PCSA Bottom chart 2.6M float Offering closed yesterday
Recent r/s name with 3 Insider buys this week and upcoming catalyst pic.twitter.com/QZjt346W0f— STOCKS Gambino (@StocksGambino) February 2, 2024
👍️0
Sweetleaf Sweetleaf 3 months ago
OFFERING CLOSED... STILL NO MOVEMENT PRESS RELEASE OUT 1 HOUR AGO.
👍️0
valleybenedetto valleybenedetto 3 months ago
Form 4 insider buys just hit.
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Offering now closed-8k
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Gonna get interesting when/if we get the filing that the offering is done
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Curling up off the lows
👍️0
TheFinalCD TheFinalCD 3 months ago
please post the spectacular chart, so we can all see
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Chart now looks spectacular. I’m fully loaded here ready for the next pop. I know it’s gonna be 5 -6 or seven bucks.
👍️0
valleybenedetto valleybenedetto 3 months ago
💪👍
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Nice …me too
👍️0
valleybenedetto valleybenedetto 3 months ago
PALI fell off a cliff too. I just grabbed a bit more PCSA here. Will continue to add now that all bad news is out of the way.
👍️0
TheFinalCD TheFinalCD 3 months ago
PCSA 2.52 missed that,
was too busy with PALI FRSX SOFI
👍️0
TheFinalCD TheFinalCD 3 months ago
yep I should have stayed away when I sold for profit
👍️0
valleybenedetto valleybenedetto 3 months ago
Company did everything in their power to ensure that happened. Very poorly managed.
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
Remember the clowns that didn’t believe me
On the pre split crash
👍️0
valleybenedetto valleybenedetto 3 months ago
Predictable but this should be at or close to bottom.
👍️0
valleybenedetto valleybenedetto 3 months ago
Sure thing. His name is Patrick Lin fyi.
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
Ouch that hurts
👍️0
TheFinalCD TheFinalCD 3 months ago
oh good to know, thanks for reaching out
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Perfect…thanks
👍️0
valleybenedetto valleybenedetto 3 months ago
Just spoke to CFO . NOT NEW. Effective on pricing. No new offering.
👍️0
TheFinalCD TheFinalCD 3 months ago
yep I took it as new, why would they file effective after they already offered?

thats putting the horse b4 the carriage right?
👍️0
valleybenedetto valleybenedetto 3 months ago
Just not sure if it's previous offering or a new one. That makes quite a difference.
👍️0
TheFinalCD TheFinalCD 3 months ago
thats why I posted and was surprised you bought after

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173723139
👍️0
valleybenedetto valleybenedetto 3 months ago
If it's a new offering this thing is dead
👍️0
TheFinalCD TheFinalCD 3 months ago
MY NEW AVG UNDER $3 NOW

BUT HOPEFULLY OUT ON BOUNCE
👍️0
TheFinalCD TheFinalCD 3 months ago
effectiveness OF DILUTION
👍️0
valleybenedetto valleybenedetto 3 months ago
Need to find out what the notice of effectiveness is for.
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Just bought 1000 more share $2.75
👍️0
valleybenedetto valleybenedetto 3 months ago
Ugly knife...yuck
👍️0
valleybenedetto valleybenedetto 3 months ago
I'm expecting insider buys. I'm sure they participated in the offering. Additional news will send it back to the 5s
👍️0
TheFinalCD TheFinalCD 3 months ago
lol dont stop now....its right @ my new average 3.35

after buying all the way down to 2.93
👍️0
valleybenedetto valleybenedetto 3 months ago
There's the turn. Nice
👍️0
TheFinalCD TheFinalCD 3 months ago
Form EFFECT - Notice of Effectiveness
January 29 2024 - 12:15AM
Edgar (US Regulatory)
👍️0
valleybenedetto valleybenedetto 3 months ago
Just took some 2.99/3.00s..should turn
👍️0
TheFinalCD TheFinalCD 3 months ago
2.93 GRRRR
👍️0
TheFinalCD TheFinalCD 3 months ago
PCSA 3.31

I SHOULD HAVE JUST SOLD ALL ON FRI

SIGH
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Time to let these Dogs Hunt-after-hours
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Starting to move up.330 pm is here. I sold 800 share increments Pre Market three different times starting at like 585 and then 597 and then I think 612. Kept 600 shares went and made myself an iced coffee and came back and she was in the 4’s. I got out with about 12 to 15 minutes to spare. Got stuck with 800 shares at my original average of under 5
👍️0
TheFinalCD TheFinalCD 3 months ago
ok my avg is 3.74 have sell set @ 4.07
-LOL
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Yea -still holding- no worries here
👍️0
Bud-Wiser Bud-Wiser 3 months ago
Actually been tied up most of the day and ironically enough it’s at 379 right now. I’m thinking we see you over five again within the next 2 trading days .. looking for 4.40 at least today -LOL
👍️0
valleybenedetto valleybenedetto 3 months ago
No. They have plenty of cash now..trials coming. Risk has been basically removed. No reason to sell.
👍️0
TheFinalCD TheFinalCD 3 months ago
what? you didnt sell on the run to 3.74?

Message in reply to:
Had some at 2.80 from other day..added 3.60s...3.25 ish avg
👍️0
valleybenedetto valleybenedetto 3 months ago
Had some at 2.80 from other day..added 3.60s...3.25 ish avg
👍️0

Your Recent History

NASDAQ
PCSA
Processa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved